Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter
Active & Responsive

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

for
Respiratory Syncytial Virus (RSV)
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT07050732

Phase 2, Recruiting
Active & Responsive

Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC

for
HCC
Location: New York NY, Baltimore MD, New Orleans LA
Sponsor: Geneos Therapeutics

Sex: All

Age: 18+

Code: NCT07722741

Phase 2, Recruiting
Active & Responsive

AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

for
Alzheimer Disease, Preclinical Alzheimer's Disease
Location: Boca Raton FL, Wellington FL, Miami Lakes FL, Stuart FL,
Sponsor: Institute for Molecular Medicine

Sex: All

Age: 65 - 70+

Code: NCT07158905

Phase 1, Recruiting
Active & Responsive

ARISe at UMass Chan

for
Vaccination, Vaccination Promotion
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 18+

Code: NCT07236034

Recruiting
Active & ResponsiveNew

RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors - High Grade Glioma

for
Recurrent High-grade Glioma
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 3 - 25

Code: NCT07949071

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Intradermal Influenza Vaccination

for
Vaccine Reaction
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07908329

Early Phase 1, Recruiting

Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy

for
COVID-19, Vaccine Hesitancy
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 24

Code: NCT05787015

Recruiting

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

for
Vaccination Failure, Vaccine Response Impaired
Location: Edmonton
Sponsor: University of Alberta

Sex: Female

Age: 18+

Code: NCT05923970

Recruiting

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

for
Vaccine Response, COVID-19 Vaccine,
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 65 - 70+

Code: NCT06821100

Phase 1, Recruiting

A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination

for
Vaccine Hesitancy, COVID-19 Testing, Community Health Workers
Location: Los Angeles CA
Sponsor: Charles Drew University of Medicine and Science

Sex: All

Age: 16+

Code: NCT05473936

Recruiting

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

for
Non-birthing Partner Vaccination in Pregnancy,
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: All

Age: 19 - 50

Code: NCT06135636

Recruiting

A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

for
Herpes Zoster, Vaccine-Preventable Diseases
Location: Secaucus NJ
Sponsor: Beijing Luzhu Biotechnology Co., Ltd.

Sex: All

Age: 50 - 70

Code: NCT05750017

Phase 1, Recruiting

Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study

for
SARS-CoV2 Infection, Covid19, Vaccine Reaction,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: Female

Age: 0+

Code: NCT05115617

Recruiting

A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families

for
Human Papilloma Virus, HPV-Related Carcinoma, Vaccine Refusal,
Location: Nashville TN
Sponsor: Meharry Medical College

Sex: All

Age: 18+

Code: NCT04380623

Recruiting

A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults

for
Vaccine Reaction
Location: Silver Spring MD
Sponsor: U.S. Army Medical Research and Development Command

Sex: All

Age: 18 - 55

Code: NCT04296279

Phase 1, Recruiting

Advancing Vaccine Equity Through Understanding Vaccine Hesitancy, Barriers, and Trust

for
Vaccine Hesitancy, Structural Barriers, Vaccine Trust
Location: Greenville NC
Sponsor: East Carolina University

Sex: All

Age: 18+

Code: NCT05537714

Recruiting

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

for
Papillomavirus Vaccines
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 8 - 70+

Code: NCT06535139

Recruiting

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

for
Squamous Cell Carcinoma of the Head and Neck, Oropharynx,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06223568

Phase 2, Recruiting

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

for
COVID-19 Vaccines
Location: Durham NC, Miami Lakes FL, Salt Lake City UT,
Sponsor: BioNTech SE

Sex: All

Age: 18 - 64

Code: NCT07730450

Recruiting

HPV Ends Here: Increasing Uptake of the HPV Vaccine

for
HPV Vaccine
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 10 - 12

Code: NCT06831929

Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial